Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Epidemiology. 2019 Jan;30(1):69–74. doi: 10.1097/EDE.0000000000000930

Table 2.

Cumulative VL (million copies/mL times days) at the end of follow-up for all participants, the end of the untreated period for those participants with untreated time, and the end of the treated period for those participants with treated time.

Mean (Millions
of copies/mL
times days)		 Median
(Millions of
copies/mL
times days)		 Standard
Deviation		 Range of VL Median
follow-up time
for time
period
All person–time 40.8 2.0 140 0.002 to 6,380 4.8 years
ART exposed
person–time		 36.1 1.0 140 0.002 to 6,380 4.4 years
ART unexposed
person–time		 37.1 10.5 84.8 0.002 to 1,550 1.8 years

ART indicates antiretroviral therapy, VL viral load.